| COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response A Zabalza, S Cárdenas‐Robledo, P Tagliani, G Arrambide, ... European journal of neurology 28 (10), 3384-3395, 2021 | 142 | 2021 |
| Multiple sclerosis management during the COVID-19 pandemic BP Moss, KR Mahajan, RA Bermel, K Hellisz, LH Hua, T Hudec, S Husak, ... Multiple Sclerosis Journal 26 (10), 1163-1171, 2020 | 80 | 2020 |
| Multiple sclerosis in Colombia and other Latin American countries J Toro, S Cárdenas, CF Martínez, J Urrutia, C Díaz Multiple Sclerosis and Related Disorders 2 (2), 80-89, 2013 | 41 | 2013 |
| Characterization of brain anatomical patterns by comparing region intensity distributions: Applications to the description of Alzheimer's disease DL Giraldo, JD García‐Arteaga, S Cárdenas‐Robledo, E Romero Brain and behavior 8 (4), e00942, 2018 | 22 | 2018 |
| The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria G Arrambide, C Espejo, P Carbonell-Mirabent, R Dieli-Crimi, ... Brain 145 (11), 3931-3942, 2022 | 20 | 2022 |
| Visual, ocular motor, and cochleo-vestibular loss in patients with heteroplasmic, maternally-inherited diabetes mellitus and deafness (MIDD), 3243 transfer RNA mutation S Cardenas-Robledo, AS Tehrani, G Blume, JC Kattah Journal of Neuro-Ophthalmology 36 (2), 134-140, 2016 | 20 | 2016 |
| HLA-DRB1* 14 is a protective allele for multiple sclerosis in an admixed Colombian population J Toro, D Cuellar-Giraldo, C Díaz-Cruz, LE Burbano, CM Guío, S Reyes, ... Neuroimmunology & Neuroinflammation 3 (1), e192, 2015 | 20 | 2015 |
| Humoral and cellular responses to SARS-CoV-2 in convalescent COVID-19 patients with multiple sclerosis A Zabalza, G Arrambide, P Tagliani, S Cárdenas-Robledo, ... Neurology: Neuroimmunology & Neuroinflammation 9 (2), e1143, 2022 | 18 | 2022 |
| Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases? A Zabalza, G Arrambide, S Otero-Romero, A Pappolla, P Tagliani, ... Multiple Sclerosis Journal 28 (7), 1138-1145, 2022 | 14 | 2022 |
| Delayed diagnosis of multiple sclerosis in a low prevalence country S Cárdenas-Robledo, L Lopez-Reyes, LE Arenas-Vargas, ... Neurological research 43 (7), 521-527, 2021 | 14 | 2021 |
| Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre A Cobo-Calvo, A Zabalza, J Río, G Arrambide, S Otero-Romero, ... Journal of Neurology, 1-9, 2022 | 9 | 2022 |
| Multiple sclerosis is associated with higher comorbidity and health care resource use: A population‐based, case–control study in a western Mediterranean region S Cárdenas‐Robledo, S Otero‐Romero, MA Passarell‐Bacardit, ... European Journal of Neurology 28 (12), 4124-4134, 2021 | 8 | 2021 |
| Prevalencia e impacto de las comorbilidades en pacientes con esclerosis múltiple S Cárdenas-Robledo, S Otero-Romero, X Montalban, M Tintoré Rev Neurol 71 (04), 151-158, 2020 | 8 | 2020 |
| Multiple sclerosis coverage in the written media of a low prevalence country S Cárdenas-Robledo, CE Navarro, CM Guío-Sánchez Multiple Sclerosis and Related Disorders 44, 102266, 2020 | 5 | 2020 |
| Prevalence and impact of comorbidities in patients with multiple sclerosis S Cardenas-Robledo, S Otero-Romero, X Montalban, M Tintoré Revista de Neurologia 71 (4), 151-158, 2020 | 5 | 2020 |
| Fertility preferences and unmet need for family planning in women with multiple sclerosis L López-Reyes, C Guío-Sánchez, C González-Uribe, ... Frontiers in Neurology 13, 1035596, 2022 | 3 | 2022 |
| Multiple sclerosis functional tests and their comparability with self-administered values: A pilot study LE Arenas-Vargas, L López-Reyes, S Cárdenas-Robledo Biomedica 43 (3), 406-417, 2023 | 2 | 2023 |
| No seasonality in the risk of multiple sclerosis in an equatorial country: A case–control ecological study S Cárdenas-Robledo, P González-Caicedo, MS Carvajal-Parra, ... Multiple Sclerosis Journal 29 (3), 343-351, 2023 | 2 | 2023 |
| COVID-19 in MS patients: susceptibility and severity risk factors A Zabalza, P Tagliani, S Cárdenas-Robledo, G Arrambide, ... Multiple Sclerosis Journal, 61-61, 2020 | 2 | 2020 |
| Humoral and cellular responses to SARS-CoV-2 vaccination in patients with multiple sclerosis and other autoimmune diseases A Zabalza, G Arrambide, S Otero-Romero, A Pappolla, P Tagliana, ... Multiple Sclerosis Journal, 769-770, 2021 | 1 | 2021 |
